Home › Peanut Hypersensitivity › Arkansas › Little Rock
Peanut Hypersensitivity clinical trials in Little Rock, AR
6 studies for Peanut Hypersensitivity are looking for participants at sites in and around Little Rock (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
RecruitingPhase 3
- Arkansas Childrens Hosp Rsch Inst, Little Rock
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
RecruitingPhase 2
- Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology, Little Rock
Study of Oral Food Challenge Biomarkers (SAFER)
RecruitingObservational study
- Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology, Little Rock
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
RecruitingPhase 1Healthy volunteers welcome
- Arkansas Children's Hospital and Research Institute, Little Rock
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
RecruitingPhase 2
- Arkansas Children's, Little Rock
Safety of MOON101 for the Treatment of Peanut Allergy
RecruitingPhase 1
- Arkansas Children's Research Institute, Little Rock
Peanut Hypersensitivity trials in other cities
- Boston, MA6 studies
- Ann Arbor, MI6 studies
- Durham, NC4 studies
- New York City, NY4 studies
- Cincinnati, OH3 studies
- Aurora, CO3 studies
- Atlanta, GA3 studies
Other studies in Little Rock
- Schizophrenia19 studies
- Cancer (all types)14 studies
- Major Depressive Disorder14 studies
- Acute Myeloid Leukemia13 studies
- Non-Small Cell Lung Cancer13 studies
- Obesity11 studies
- Endometrial Cancer10 studies
- Type 2 Diabetes10 studies
- Depression10 studies
- Bladder Cancer9 studies
- Lung Cancer9 studies
- Heart Failure9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.